United States Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Neuromodulation Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Deep Brain Stimulators (DBS) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Gastric Electric Stimulators (GES) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Peripheral Nerve Stimulators (PNS) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.4 Sacral Nerve Stimulators (SNS) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.5 Spinal Cord Stimulators (SCS) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.6 Vagus Nerve Stimulators (VNS) Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Deep Brain Stimulators (DBS) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Gastric Electric Stimulators (GES) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Peripheral Nerve Stimulators (PNS) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.4 Sacral Nerve Stimulators (SNS) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.5 Spinal Cord Stimulators (SCS) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.6 Vagus Nerve Stimulators (VNS) Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, United States, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Neuromodulation Devices Market, United States, Company Share by Revenue ($m), 2023

4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 LivaNova Plc
4.4.1 Company Overview
4.5 Nevro Corp
4.5.1 Company Overview
4.6 Axonics Inc
4.6.1 Company Overview

6.1 Acquisition
6.1.1 DuPont de Nemours Acquires Donatelle Plastics
6.2 Asset Transactions
6.2.1 ReShape Lifesciences to Sell Assets to Biorad Medisys for USD5.16 Million
6.3 Debt Offerings
6.3.1 Sanuwave Health Raises USD1.8 Million in Debt Financing
6.3.2 Boston Scientific Raises USD2.1 Billion in Private Placeement of 3.375% Senior Notes due 2029
6.4 Equity Offerings
6.4.1 ElectroCore Files Prospectus to Raise Funds in Public Offering of Shares
6.4.2 ElectroCore Raises USD7.76 Million in Private Placement of Shares
6.4.3 Helius Medical Technologies Prices USD6.4 Million for Public Offering of Shares
6.4.4 Blackrock Microsystems (I2S Micro Implantable Systems) Raises USD12.36 Million in Equity Offering
6.4.5 Vivani Medical Plans to Raise Upto USD300 Million in Public Offering
6.4.6 Vivani Medical to Raise USD75 Million in Public Offering of Common Stock
6.5 Venture Financing
6.5.1 ShiraTronics Raises USD66 Million in Series B Financing
6.5.2 Neuspera Medical Raises USD23 Million in Series D Financing
6.5.3 Juniper Biomedical Secures USD2 Million in Seed Funding

7.1 Corporate Communications
7.1.1 Jan 13, 2025: SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales
7.2 Financial Announcements
7.2.1 Jan 13, 2025: SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024)
7.2.2 Nov 12, 2024: Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
7.2.3 Nov 08, 2024: SANUWAVE Posts Financial Results for Three Months Ended September 30, 2024
7.2.4 Nov 04, 2024: SANUWAVE Will Host a Conference Call on November 8,2024 at 8:30 AM (ET) to Present Q3 Financial Results
7.2.5 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.6 Oct 23, 2024: electroCore to Announce Third Quarter September 30,2024 Financial Results on Wednesday, November 13, 2024
7.2.7 Oct 17, 2024: ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
7.2.8 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.2.9 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
7.2.10 Aug 06, 2024: Helius Medical Technologies to Release Second Quarter 2024 Financial Results on August 12, 2024
7.2.11 Jul 31, 2024: Avanos Medical Announces Second Quarter 2024 Results
7.2.12 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
7.2.13 Jul 09, 2024: Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
7.2.14 Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
7.3 Government and Public Interest
7.3.1 Nov 20, 2024: Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
7.3.2 Sep 04, 2024: electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
7.3.3 Jul 31, 2024: Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
7.4 Other Significant Developments
7.4.1 Dec 23, 2024: Helius Medical Technologies Announces First PoNS System Sale to VA Healthcare System
7.4.2 Aug 20, 2024: Neurostar Marks Two Years Of Transformative Impact With Neurostar University
7.4.3 Jul 17, 2024: Max Planck Florida Institute for Neuroscience Researcher Receives $11 Million to Lead National Research Collaboration
7.4.4 Jun 24, 2024: Chen Awarded Two Scialog Grants to Study the Molecular Basis of Cognition
7.5 Product News
7.5.1 Feb 06, 2025: Electrocore Expands Intellectual Property Portfolio
7.5.2 Feb 03, 2025: Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025
7.5.3 Jan 28, 2025: Integer To Highlight Innovations in Neuromodulation, Next Generation of Miniaturized Active Implantable Devices During Nans 2025 Annual Meeting
7.5.4 Jan 07, 2025: electroCore Granted Five New U.S. Patents
7.5.5 Oct 15, 2024: AcuityMD Launches ‘Care Journeys’ to Help MedTech Companies Speed Delivery of Breakthrough Innovation to the Right Patients
7.5.6 Sep 16, 2024: Synchron Announces First Use of Amazon’s Alexa with a Brain Computer Interface
7.5.7 Apr 30, 2024: Truvaga Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
7.6 Strategy And Business Planning
7.6.1 Mar 19, 2024: Gastroenterology Group of Naples Introduces Innovative Axonics Sacral Neuromodulation Therapy

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Deep Brain Stimulators (DBS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Gastric Electric Stimulators (GES) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Peripheral Nerve Stimulators (PNS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Sacral Nerve Stimulators (SNS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 6: Spinal Cord Stimulators (SCS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 7: Vagus Nerve Stimulators (VNS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 8: Neuromodulation Devices Market, United States, Volume (Units), 2018-2033
Table 9: Deep Brain Stimulators (DBS) Market, United States, Volume (Units), 2018-2033
Table 10: Gastric Electric Stimulators (GES) Market, United States, Volume (Units), 2018-2033
Table 11: Peripheral Nerve Stimulators (PNS) Market, United States, Volume (Units), 2018-2033
Table 12: Sacral Nerve Stimulators (SNS) Market, United States, Volume (Units), 2018-2033
Table 13: Spinal Cord Stimulators (SCS) Market, United States, Volume (Units), 2018-2033
Table 14: Vagus Nerve Stimulators (VNS) Market, United States, Volume (Units), 2018-2033
Table 15: Neuromodulation Devices Market, United States, Average Price ($), 2018-2033
Table 16: Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 17: Neuromodulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 18: Neuromodulation Devices Market Pipeline Products
Table 19: DuPont de Nemours Acquires Donatelle Plastics
Table 20: ReShape Lifesciences to Sell Assets to Biorad Medisys for USD5.16 Million
Table 21: Sanuwave Health Raises USD1.8 Million in Debt Financing
Table 22: Boston Scientific Raises USD2.1 Billion in Private Placeement of 3.375% Senior Notes due 2029
Table 23: ElectroCore Files Prospectus to Raise Funds in Public Offering of Shares
Table 24: ElectroCore Raises USD7.76 Million in Private Placement of Shares
Table 25: Helius Medical Technologies Prices USD6.4 Million for Public Offering of Shares
Table 26: Blackrock Microsystems (I2S Micro Implantable Systems) Raises USD12.36 Million in Equity Offering
Table 27: Vivani Medical Plans to Raise Upto USD300 Million in Public Offering
Table 28: Vivani Medical to Raise USD75 Million in Public Offering of Common Stock
Table 29: ShiraTronics Raises USD66 Million in Series B Financing
Table 30: Neuspera Medical Raises USD23 Million in Series D Financing
Table 31: Juniper Biomedical Secures USD2 Million in Seed Funding
Table 32: Total Number of Primary Research Participants, Neurology Devices Market, by Country

Figure 1: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Deep Brain Stimulators (DBS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Gastric Electric Stimulators (GES) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Peripheral Nerve Stimulators (PNS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Sacral Nerve Stimulators (SNS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 6: Spinal Cord Stimulators (SCS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 7: Vagus Nerve Stimulators (VNS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 8: Neuromodulation Devices Market, United States, Volume (Units), 2018-2033
Figure 9: Deep Brain Stimulators (DBS) Market, United States, Volume (Units), 2018-2033
Figure 10: Gastric Electric Stimulators (GES) Market, United States, Volume (Units), 2018-2033
Figure 11: Peripheral Nerve Stimulators (PNS) Market, United States, Volume (Units), 2018-2033
Figure 12: Sacral Nerve Stimulators (SNS) Market, United States, Volume (Units), 2018-2033
Figure 13: Spinal Cord Stimulators (SCS) Market, United States, Volume (Units), 2018-2033
Figure 14: Vagus Nerve Stimulators (VNS) Market, United States, Volume (Units), 2018-2033
Figure 15: Neuromodulation Devices Market, United States, Company Share (%) 2023